Teva scraps cluster headache program

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 23, 2019 at 10:32 AM.

  1. #1 cafead, Apr 23, 2019 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches.

    The company said the decision was taken after an analysis of late-stage study data showed that the drug was unlikely to meet the main goal of the trial.

    article source
     
    Quote

Reply to Thread